JFGIW
CLRB icon

Johnson Financial Group Inc (Wisconsin)’s Cellectar Biosciences CLRB Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18
Closed -$2K – 657
2022
Q2 		$2K Hold
18
– – ﹤0.01% 600
2022
Q1 		$4K Hold
18
– – ﹤0.01% 620
2021
Q4 		$4K Hold
18
– – ﹤0.01% 648
2021
Q3 		$5K Hold
18
– – ﹤0.01% 575
2021
Q2 		$7K Buy
18
+3
+20% +$1.3K ﹤0.01% 579
2021
Q1 		$7K Buy
+15
New +$8.92K ﹤0.01% 563

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s CLRB Position: Q3 2022 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Cellectar Biosciences (CLRB) in Q3 2022, closing a stake of 18 shares — an estimated $2K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in CLRB in Q1 2021 and held it in 6 quarters. The position peaked at $7K in Q2 2021. 20 funds tracked by Wall St. Rank hold CLRB as of Q3 2022.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Cellectar Biosciences position as of Q3 2022 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 18 Cellectar Biosciences shares in Q3 2022, an estimated $2K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Cellectar Biosciences in Q1 2021 and held it in 6 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Cellectar Biosciences position peaked at $7K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2022.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q3 2022, filed 14 Nov 2022.